Search PubMed⌕ Search

Biomedical subjects

B Kubanek

Publications and source records attributed to B Kubanek.

At least 127 records · Page 7Linked to original sources

Extrarenal erythropoietin production by macrophages.

Murine bone marrow and adherence-separated spleen cells cultured on hydrophobic, gas-permeable Teflon foils (petriperm dishes) can be shown to synthesize and secrete erythropoietin (Epo) and colony-stimulating activity (CSA) simultaneously into the surrounding medium. The Epo activity in the supernatants of primary cultures as measured by the fetal liver erythroid colony-forming technique, from adherent and nonadherent spleen cells, increases over the first 7 days in culture, followed by a plateau until 14 days. Use of the macrophage-specific cytotoxic agent, crystalline silica, as a tool to release residual Epo contained in these cells produces a similar time-Epo activity curve to that found in the primary supernatants. This, together with functional and morphological examination of the cells, indicates that macrophages are responsible for this activity. The total Epo activity released from adherent and nonadherent spleen cells at plateau levels was estimated to be 25 mU/ml culture/day. Weekly subcultivation of bone marrow and adherence-separated spleen cells initiated from primary cultures demonstrated a massive increase in both Epo activity and CSA above that obtained for the primary cultures. Subcultivation could be continued for at least 6 wk. These results, together with the reversible inhibition of Epo and CSA production by cycloheximide, demonstrate that these molecules are synthesized by the macrophage. The evidence supports the hypothesis that the macrophage is involved not only in extrarenal Epo production, but also in the possible short-range regulation of hemopoiesis.

Animals↗

A milker for mice.

A new apparatus for milking mice was used to obtain milk from four anesthetized mice simultaneously over a period of 15 minutes. By using silicon rubber molded teat cups, eight teats could be milked automatically from each mouse. The average yield was 1.5 ml per mouse. This method was especially applicable to production of large amounts of mouse milk. Milking of rats was achieved with the apparatus without any changes.

Animals↗

Isolation of mouse transferrin using salting-out chromatography on Sepharose CL-6B.

A new method for the isolation of considerable quantities of mouse transferrin is described. This technique employs salting-out chromatography on Sepharose CL-6B, a new step in the preparation of plasma proteins. This step is followed by ion-exchange chromatography on DEAE-Sepharose CL-6B and gel filtration on Sephacryl S-200. The isolated mouse transferrin was shown to be pure by immunoelectrophoresis, sodium dodecyl sulphate-polyacrylamide gel electrophoresis and by the 465 nm/410 nm ratio of absorbances being 1.41. The molecular weight was determined to be about 77 500. The advantages of this procedure are that it is reproducible, gives a high recovery, and can be extended to a larger scale. The advantage over other protein purification techniques is its general utility, due to the fact that there is no need for species-specific antibodies. The application of this method offers a rapid purification of sufficient quantities of mouse transferrin essential for the elucidation of biological functions of this protein and investigations of its molecular structure.

Animals↗

Release of erythropoietin from macrophages by treatment with silica.

An erythropoietic stimulating factor (ESF) can be shown to be released from preincubated macrophage-containing cell suspensions from mice by the macrophage-specific, cytotoxic agent, silica. A concentrated silica-treated spleen cell supernatant containing ESF is shown to cause a dose-dependent increase in 59Fe incorporation into red blood cells using the in vivo polycythemic mouse bioassay. The ESF from the same supernatant can also be neutralized by anti-erythropoietin. A second concentrated supernatant fractionated using wheat germ lectin-Sepharose 6MB and compared to either unfractionated or fractionated step III erythropoietin (Ep), tested in vitro using the erythroid colony-forming technique and 12-day fetal liver as target cells, indicates parallelism of all linear dose-response lines. This, together with the in vivo data, strongly suggests that the ESF released from macrophages treated with silica is, in fact, Ep. Substituting Ca2+ ions for fetal calf serum in the preincubation procedure results in the same activity being released compared to the presence of 1% or 20% fetal calf serum.

Animals↗

Specific enhancement of mouse CFU-E by mouse transferrin.

Pure human and mouse transferrins were prepared by a chromatographic procedure and their effect on the growth of early (BFU-E) and late (CFU-E) erythropoietic precursors in mouse bone marrow is described. In the presence of optimal erythropoietin concentrations mouse bone marrow cells have a greater specificity for mouse transferrin (950 CFU-E colonies/10(5) cells) than human transferrin (650 CFU-E colonies/10(5) cells). Optimal transferrin concentrations for both human and mouse transferrins were 1.3x10(-13)M and 1.3x10(-10)M corresponding to between 7.8x10(7) and 7.8x10(10) molecules/ml of culture. These concentrations are in excess of that calculated on a theoretical basis. Neither erythropoietic burst nor granulocyte/macrophage colony formation exhibited a dose dependent relationship for any of the transferrins employed, although higher colony numbers were obtained with mouse transferrin compared to human transferrin.

Animals↗

Granulocyte transfusions in acute leukaemia. Regeneration of granulopoiesis as determining factor of survival.

40 patients with acute leukaemia and severe granulocytopenia were treated with granulocyte transfusions for bacteriologically documented or clinically suspected septicaemia. The patients received an average of 5 transfusions each with 2.1 X 10(10) granulocytes per m2 body surface area per day. 26 patients showed clinical benefit from transfusion therapy as documented by the course of blood cultures, local lesions and fever. Only patients with regeneration of granulopoiesis had definite benefit from granulocyte transfusions. All other patients died ultimately from septicaemia.

Acute Disease↗

[Deep frozen fresh plasma in blood component therapy: preparation--quality control--indications].

Fresh frozen plasma is prepared within 6 hrs after collection in a double bag system. A second centrifugation at 4600 x g is necessary to obtain a platelet poor plasma. A special bag freezing system fitted to a conventional cryostat and cooled with ethanol to -50 degrees C was developed to reach the required cooling rate. It is possible to freeze 25 plasma bags simultaneously within 30 min in this new apparatus. Fresh frozen plasma prepared in this manner contains all coagulation factors and inhibitors with almost normal activities. Freezing at -40 degrees C in the air, prolonged storage of the starting material, or insufficient cooling of the frozen product deteriorate its quality. The influence of these variables with the discussed in detail. Indications of fresh frozen plasma, especially for dilution- and posttraumatic consumption coagulopathy as well as liver disease, are presented.

Blood Preservation↗

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia was studied retrospectively in 47 patients who were treated with a standardized aggressive chemotherapy of daunorubicin and cytosine arabinoside. Twenty-two patients were treated in strict reverse isolation with antimicrobial decontamination and 25 patients in the open ward without any measures against infections. In the patients in isolation the incidence of new infections per patient was 0.77 compared to 1.42 in the control group. The rate of complete remissions was 77% in the patients in isolation vs. 56% in the control patients.

Acute Disease↗

An erythropoietic stimulating factor similar to erythropoietin released by macrophages after treatment with silica.

An erythropoietic stimulating factor (ESF) can be detected in the supernatant from fetal liver and adult bone marrow and spleen cells when preincubated with the macrophage-specific cytotoxic agent, silica. Stimulation is observed in 12-day fetal liver CFU-E cultures in the absence of added erythropoietin (Ep). The concentration of ESF in the supernatant added to CFU-E cultures is dependent on the preincubated cell dose and the volume added. The stimulating activity is abolished when mice are hypertransfused and increased above normal values when mice are bled. A concentrated silica-treated spleen supernatant was able to stimulate erythropoiesis in the polycythemic mouse bioassay. It is concluded that the ESF is similar, if not identical, to Ep.

Anemia↗

The effect of actinomycin D on hemopoiesis. I. Short-term effects.

The effect of in vivo administration of actinomycin D (Act D) on the hemopoietic precursor compartments and, in particular, the BFU-E, CFU-E, and erythroblast populations was investigated over a 6-day period. Daily injections of mice with 15 microgram/kg, 30 microgram/kg, and 60 microgram/kg Act D showed a dose-dependent effect. The highest dose caused an almost complete eradication of CFU-E as well as the morphologically identifiable erythroblasts. There was no appreciable reduction in BFU-E, GM-CFU, and CFU-S. These observation indicate that Act D interferes with erythropoiesis by selectively inhibiting the CFU-E compartment. The effects are not due to altered sensitivity to erythropoietin as dose response curves were similar for control and Act D-treated cells. Although a considerable reduction in CFU-E is observed and approximately 20-30% of nucleated cells are lost from the small size region, there is no displacement in the velocity sedimentation profiles either from the remaining CFU-E and nucleated cell populations or the BFU-E and GM-CFU populations.

Animals↗

Micromegakaryocytes in Human Bone Marrow.

Micromegakaryocytes (MMK) were defined morphologically by the cell area, nucleus form and cytoplasmic structure. Bone marrow smears of 7,156 patients were retrospectively analyzed. MMK were found most frequently and abundantly in acute non-lymphatic leukaemia, chronic myeloid leukaemia and pre-leukaemia. The presence of more than 10% MMK in the megakaryocyte population suggest a pre-leukaemic condition or non-lymphatic leukaemia. The platelet production of MMK is probably quantitatively normal although a functional defect is suspected.

Acute Disease↗

Endotoxin-induced changes in the interrelationship of density subpopulations of granulocyte-macrophage progenitor cells.

Progenitor cells of in vitro colonies of granulocytes and/or macrophages (CFU-s'c) constitute a functionally heterogeneous population reflected by differences in their bouyant density. The interrelationship of density subpopulations of murine (CFU-c, obtained by isopycnic centrifugatiuon of bone marrow cells in continuous albumin density gradients, was examined in perturbed states induced by endotoxin injection. Femoral bone marrow CFU-c's were investigated at daily intervals for 3 days after injection of endotoxin. A distinct difference was found between the changes in CFU-c when detected in vitro with MLCM and HU as the sources of CSF. After 1 day, there was a reduction in the number of CFU-c's, in particular by those CFU-c's of low density (< 1.07 gm/cm3) that are detectable in vitro with CSFMLCM and that form predominantly granulocytic colonies. This was followed on day 2 by the reappearance of this subpopulation. In contrast, those CFU-c's detectable with CSFHU and forming predominantly macrophage colonies were characterized by a high modal density (> 1.075 gm/cm3). Their numbers decreased on day 1, increased by day 2, and further increased above control levels by day 3 when they were characterized by a very high mean modal density of 1.087 gm/cm3. These results indicate that the different types of CSF detect subpopulations of CFU-c's that differ in differentiation potential and perhaps constitute a hierarchy in the myelopoietic pathway.

Animals↗

The ontogeny of erythropoiesis in the mouse detected by the erythroid colony-forming technique. II. Transition in erythropoietin sensitivity during development.

The erythroid colon-forming technique has been used to study the erythropoietin (Ep) sensitivity of CFU-E during ontogenesis. Evidence is provided which indicates that an age-related decreasing Ep sensitivity of CFU-E occurs as the animal develops. In addition, an intermediate Ep-sensitive CFU-E population represented by the 2-day-old neonate is present during the transition from foetus to adult. The Ep sensitivity of the foetal, neonatal and adult CFU-E populations is shown to be an intrinsic property of these populations.

Aging↗